Gemita 200 MG Injection

Gemita 200 MG Injection is an anticancer chemotherapy drug. This includes treatment for ovarian cancer, breast cancer, lung cancer, bladder cancer, pancreatic cancer and soft tissue sarcoma. It is also sold under the trade name of Gemzar. Gemita 200 MG Injection can also be used in combination with other medications as supervised by your doctor. It is an antimetabolite drug. Gemita 200 MG Injection is only injected into your vein by IV injection or IV infusion.

Side effects may vary from one person to another. Some people may not experience all of them at the same time. But mainly the common side effects of using Gemita 200 MG Injection include fever, mild nausea, diarrhea, hair loss, tiredness, loss of appetite, flu- like signs, eruptions on the skin and low blood count. Should effects continue inform your health care provider.

Before embarking on your Gemita 200 MG Injection treatment, notify your doctor of the following pre-existing conditions, if any:

• If you are already taking any kind of medications, whether it be prescriptive, non-prescriptive, herbal and vitamins .
• If you are taking any vaccinations.
• You are allergic to any kind of foods, to Gemita 200 MG Injection itself or are receiving radiation treatment.
• If you are pregnant or planning to become pregnant or are breastfeeding a baby.

As a preventive measure, please do not try to conceive a child while under Gemita 200 MG Injection treatment. For both men and women use all kinds of barriers of contraception during this time. Other measures that you can take to keep the side effects at bay include getting yourself regularly checked by your doctor; keeping yourself warm at all possible times to avoid flu or fever; making sure to avoid bleeding as much as possible; drinking plenty of fluids every day; keeping yourself clean at all times, avoiding exposure to the sun by using an umbrella or sunscreen with a minimum of SPF 15 and maintaining a healthy diet and lifestyle.

Gemita 200 MG Injection dosage for each person is determined by taking into consideration their individual weight, height, general health and medical history. Gemita 200 MG Injection should given to you by trained hands only. When buying a bottle of Gemita 200 MG Injection please ensure that it is not cloudy or contains particles.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Pancreatic Cancer

  Gemita 200 MG Injection is used along with other medications in the treatment of pancreatic cancer.

• Non-Small Cell Lung Cancer

  Gemita 200 MG Injection is used along with other medications in the treatment of lung cancer.

• Breast Cancer

  Gemita 200 MG Injection is used along with other medications in the treatment of breast cancer.

• Ovarian Cancer

  Gemita 200 MG Injection is used along with other medications in the treatment of ovarian cancer.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Allergy

  Not recommended in patients with known allergy to Gemita 200 MG Injection

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Low Wbc Count

• Pale Skin

• Fever

• Nausea Or Vomiting

• Diarrhoea

• Weakness In Arms, Hands, Legs Or Feets

• Headache

• Hair Loss Or Thinning Of The Hair

• Drowsiness

• Skin Rash

• Swelling And Redness At The Injection Site

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• How long is the duration of effect?

  The effect of this medicine lasts for an average duration of 2 to 5 hours.

• What is the onset of action?

  The peak effect of this medicine can be observed immediately after intravenous injection.

• Are there any pregnancy warnings?

  This medicine is not recommended for pregnant women.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  This medicine is not recommended in breastfeeding women.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Gemita 200 MG Injection , and hence can be used as its substitute.

• Cytogem 200 MG Injection

  Dr. Reddys Laboratories Ltd

• Emcitaben 200 MG Injection

  Rpg Life Sciences Ltd

• Gemitrate 200 MG Injection

  Torrent Pharmaceuticals Ltd

• Tabicad 200 MG Injection

  Cadila Pharmaceuticals Ltd

• Xtroz 200 MG Injection

  Ranbaxy Laboratories Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Missed Dose instructions

  It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately.

• Are there any overdose instructions?

  Seek emergency medical treatment or contact the doctor in case of an overdose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• India

• United States

• Japan

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

This medicine belongs to the antimetabolite class of drugs. After ingestion, it metabolized and form diphosphate and triphosphate nucleosides. Diphosphate nucleoside inhibits ribonucleotide reductase which generates deoxynucleoside triphosphates which are essential for DNA synthesis. Thus, the gemcitabine triphosphate competes with deoxynucleoside triphosphates for incorporation into DNA and interferes with DNA synthesis, results in cell death.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Alcohol

  Alcohol

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Interaction with Lab Test

  Lab

  Information not available.

• Interaction with Medicine

  Clozapine

  These medicines may further lower the white blood cell count if received together. Any symptoms of fever, diarrhea, sore throat, chills should be informed to the doctor. Close monitoring of blood cell count is necessary. An alternate medicine should be considered based on the clinical condition.

  Warfarin

  These medications may increase the risk of bleeding if taken together. Close monitoring of platelets count and liver function is necessary. Any symptoms of unusual bleeding, blood in stools, yellow colored eyes and skin should be informed to the doctor. The dose of warfarin or Gemita 200 MG Injection should be adjusted based on the clinical condition.

  Live vaccines

  You may be at the risk of developing infections if these medicines are taken together. Inform the doctor if you had received either of these medicines. Your doctor may postpone therapy based on the condition.

  Fluoroquinolone antibiotics

  The effect of antibiotics like ciprofloxacin, ofloxacin, levofloxacin may reduce if taken with anti-cancer agents. The dose of these antibiotics should be adjusted. An alternate class of antibiotic could be considered based on the clinical condition.

• Interaction with Disease

  Disease

  Information not available.

• Interaction with Food

  Food

  Information not available.

• Gemcitabine-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 4 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/gemcitabine

• Gemcitabine-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 4 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00441

• GEMCITABINE injection,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 4 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=GEMCITABINE